GENOME ENGINEERING COMES
FULL CIRCLE
Delivering Non-Viral Life-Saving Genomic Medicine
Full Circles Therapeutics is transforming genome engineering with our unique, nonviral, targeted genomic integration technology to treat genetic diseases, autoimmune diseases and cancer. Our vision is to enable cell and gene therapies by providing a scalable platform that helps create a world free of these disorders.
Our technology is supported by a team boasting 20+ years of experience in the CGT market. Not only are we innovating more efficient genome engineering techniques but also reducing their costs to make them more accessible.
Technology
Our GATALYST platform delivers circular, single-stranded DNA for integration into defined genomic location in disease-relevant cell types, with no limitations on the size of the donor DNA sequence.
With our targeted genome engineering approach, we are dedicated to discovering, developing, and manufacturing novel and curative genomic therapies. We aim to bridge the gap between technology and treatment – bringing gene editing full circle to forge a brighter future for patients and their families.
Latest News
Contact Us
Let’s join hands to achieve a world without genetic disorders.
We are looking to form strategic partnerships for cell engineering workflows and cell line development alongside rapid manufacturing of biologics, including CAR-T cells and hematopoietic stem cells. Feel free to explore our current pipelines in development or reach out to talk with us about a new possibility. We can also license our technology to support your workflows.